The prelude network® names labcorp its preferred genetic carrier screening lab

Expanded partnership to help increase patient access to critical genetic screening services including genetic counseling and test result turnaround time  houston , march 29, 2024 /prnewswire/ -- the prelude network®  (prelude), the largest network of fertility clinics in north america, announced today an expansion of its partnership with labcorp (nyse: lh), a global leader of innovative diagnostic and biopharma laboratory services, to serve as its preferred genetic carrier screening lab. labcorp has long been a partner to prelude and its expansive network of more than 90 clinics across the u.s. and in parts of canada, providing clinical laboratory and fda-approved donor testing within each clinic.
LH Ratings Summary
LH Quant Ranking